Get the Stockscreener App
262.23
1.93%
-5.15
After Hours:
263.00
0.77
+0.29%
Overview
News
Price History
Option Chain
Financials
Why CI Down?
Discussions
Forecast
Stock Split
Dividend History
Cigna Group stock is traded at $262.23, with a volume of 3.43M.
It is down -1.93% in the last 24 hours and down -21.58% over the past month.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.
See More
Previous Close:
$267.38
Open:
$269.49
24h Volume:
3.43M
Relative Volume:
1.85
Market Cap:
$70.05B
Revenue:
$254.47B
Net Income/Loss:
$5.03B
P/E Ratio:
14.52
EPS:
18.06
Net Cash Flow:
$6.01B
1W Performance:
-11.52%
1M Performance:
-21.58%
6M Performance:
-10.87%
1Y Performance:
-21.16%
1-Day Range:
$256.89
$271.00
1-Week Range:
$256.89
$298.71
52-Week Range:
$256.89
$370.82
Cigna Group Stock (CI) Company Profile
Name
Cigna Group
Sector
Industry
Phone
(860) 226-6000
Address
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Compare CI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
262.23 | 79.57B | 254.47B | 5.03B | 6.01B | 18.06 |
|
UNH
Unitedhealth Group Inc
|
237.77 | 241.34B | 422.82B | 21.30B | 25.27B | 23.08 |
|
CVS
Cvs Health Corp
|
62.47 | 78.81B | 378.96B | 5.28B | 5.94B | 4.19 |
|
ELV
Elevance Health Inc
|
274.66 | 66.10B | 189.25B | 5.36B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
247.26 | 31.45B | 117.76B | 1.21B | 2.39B | 9.95 |
Cigna Group Stock (CI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-06-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Feb-05-24 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-05-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-01-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-04-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-11-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| Jun-06-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Neutral |
| Apr-05-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-03-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Nov-21-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Jul-14-22 | Downgrade | Jefferies | Buy → Hold |
| Jun-22-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Hold |
| May-27-22 | Resumed | Bernstein | Mkt Perform |
| May-26-22 | Upgrade | BofA Securities | Underperform → Neutral |
| May-16-22 | Upgrade | JP Morgan | Neutral → Overweight |
| May-09-22 | Upgrade | Cowen | Market Perform → Outperform |
| Feb-07-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-21-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-17-21 | Initiated | Seaport Research Partners | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Mkt Perform |
| Sep-10-21 | Downgrade | BofA Securities | Buy → Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-06-21 | Reiterated | BofA Securities | Buy |
| Aug-06-21 | Reiterated | Citigroup | Buy |
| Aug-06-21 | Reiterated | Deutsche Bank | Buy |
| Aug-06-21 | Reiterated | Jefferies | Buy |
| Aug-06-21 | Reiterated | Mizuho | Buy |
| Aug-06-21 | Reiterated | Oppenheimer | Outperform |
| Aug-06-21 | Reiterated | Truist | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-04-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-24-20 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-11-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Aug-06-19 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Apr-23-19 | Initiated | UBS | Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-24-18 | Initiated | Edward Jones | Buy |
| Mar-13-18 | Initiated | Bernstein | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Overweight |
| Jan-03-18 | Initiated | Goldman | Neutral |
| Nov-03-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-22-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-12-17 | Initiated | Credit Suisse | Outperform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-08-17 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
View All
Cigna Group Stock (CI) Latest News
Cigna's Q2 2025 Earnings: Can Strategic Growth Offset Profit Stagnation for Long-Term Investors? - AInvest
The Cigna (CI) Group Falls 10% as Earnings Disappoint - Insider Monkey
Cigna Plunges 3.33% Amid Earnings Volatility and Sector Turmoil – What’s Next for CI? - AInvest
Why Cigna (CI) is a Great Dividend Stock Right Now - Yahoo Finance
Cigna Group's Strategic Resilience: Navigating Stop-Loss Challenges in a High-Cost Healthcare Era - AInvest
Cigna Group's Balanced Play Keeps Analysts On Board - Finimize
Cigna stock hits 52-week low at 261.66 USD - Investing.com Australia
Cigna stock hits 52-week low at 261.66 USD By Investing.com - Investing.com India
Cigna beats investor expectations on Evernorth growth - Healthcare Dive
The Cigna Group (NYSE:CI) Q2 2025 Earnings Call Transcript - Insider Monkey
Cigna Group reports US$1.5 billion in net income - Insurance Business America
Cigna Group reveals US$1.5 billion in net income - Insurance Business America
Cigna Group posts $1.5 billion in net income - Insurance Business America
The Cigna Group (CI) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid Cost Pressures - Yahoo Finance
The Cigna Group (CI) Q2 2025 Earnings Call Highlights: Strong Re - GuruFocus
Cigna Group Reports Strong Q2 2025 Earnings - TipRanks
Decoding The Cigna Group (CI): A Strategic SWOT Insight - GuruFocus
Massive Sell-Off: 10 Stocks in a Bloodbath - Insider Monkey
Cigna Stock Slides 8% On Thursday But Wells Fargo Analyst Is Surprised: Here’s What Happened By Stocktwits - Investing.com India
Cigna’s Earnings Call: Strong Results Amid Challenges - TipRanks
Cigna Group stock underperforms Thursday when compared to competitors - MSN
Cigna's solid Q2 results boosted by Evernorth revenue growth, limited exposure to elevated medical costs - Fierce Healthcare
Cigna Stock Slides 8% On Thursday But Wells Fargo Analyst Is Surprised: Here’s What Happened - Stocktwits
What are The Cigna Group company’s key revenue driversAI Powered Tips For 2025 - jammulinksnews.com
Cigna's Positive Second Quarter Numbers Reflect Shift to Pharmaceutical Services - Managed Healthcare Executive
Cigna Group (CI) Reports Q2 Revenue Surge To US$67,178 Million, Net Income Flat - simplywall.st
Cigna Group SEC 10-Q Report - TradingView
Cigna battles hospitals' AI billing systems in escalating health care cost fight - BenefitsPRO
Cigna reaffirms guidance despite elevated medical costs - Healthcare Finance News
Cigna Q2 Earnings Beat Estimates on Higher Specialty Volumes - Yahoo Finance
Earnings call transcript: Cigna Q2 2025 beats earnings estimates, stock dips By Investing.com - Investing.com Canada
Cigna Sees Elevated Cost Trends To Continue Into Next Year - Benzinga
Earnings call transcript: Cigna Q2 2025 beats earnings estimates, stock dips - Investing.com
Cigna Stock Falls on Earnings Even as It Sidesteps the Managed-Care Crisis - Barron's
Cigna's health services business powers Q2 earnings beat - Reuters
Cigna affirms outlooks as Evernorth Health Services drives growth - Modern Healthcare
Cigna beats profit estimate on robust health services growth - Reuters
Cigna: Q2 Earnings Snapshot - The Washington Post
Cigna’s 2nd quarter profits beat Wall Street’s expectations - Fast Company
Cantor Fitzgerald reiterates Overweight rating on Cigna stock at $365 - Investing.com Australia
Cigna Group reports results for the quarter ended June 30Earnings Summary - TradingView
Cigna (CI) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo.co
The Cigna Group (CI): Oversold on the Charts, Solid in the Fundamentals - MSN
Cigna Group shares rise as Q2 results top estimates - Yahoo Finance
Cigna Group shares rise as Q2 results top estimates By Investing.com - Investing.com India
Cigna (NYSE:CI) Reports Strong Q2 - FinancialContent
The Cigna Group Reports Strong Second Quarter 2025 Results - TradingView
The Cigna Group Reports Q2 2025 Earnings: Revenue Surpasses Esti - GuruFocus
The Cigna Group Q2 Profit Beats Estimates - Nasdaq
Cigna Corp. (CI) Tops Q2 EPS by 4c, Beats on Revenue; Offers FY25 EPS Guidance - StreetInsider
The Cigna Group Reports Strong Second Quarter 2025 Results, Reaffirms 2025 Adjusted EPS Outlook - MarketScreener
Cigna Group Stock (CI) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.03%
0.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):